Abbott To Acquire Cephea Valve Technologies, Inc.
Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment
Source: Abbott.com - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Heart | Heart Valve Disease | Heart Valves | Mergers and Aquisitions | Pharmaceuticals